Comparing Virtual Yoga to Standard Care on Insomnia Among Cancer Survivors
A Feasibility Trial Comparing the Effectiveness of Virtual YOCAS©® Yoga to Standard Care for Treating Insomnia in Cancer Survivors
1 other identifier
interventional
42
1 country
2
Brief Summary
This feasibility phase II randomized controlled trial examines the preliminary efficacy of our standardized four-week YOCAS©® (Yoga for Cancer Survivors) intervention that is delivered virtually on insomnia and sleep quality in cancer survivors. Insomnia can be described as excessive daytime napping, difficulty falling asleep, difficulty staying asleep, or waking up earlier than desired. The vast majority of patients with cancer experience some form of sleep impairment post-treatment. Yoga is safe, feasible, and effective for improving insomnia and sleep quality in cancer survivors. However, most of the yoga intervention was delivered in person. With the challenges and the social distancing regulation regarding the COVID-19 pandemic, adapting to virtual behavioral intervention is critically important and needed. Whether the yoga intervention delivered virtually to survivors provides a similar benefit of improving insomnia and sleep quality is unknown.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2022
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 30, 2020
CompletedFirst Posted
Study publicly available on registry
July 7, 2020
CompletedStudy Start
First participant enrolled
January 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
ExpectedApril 16, 2026
April 1, 2026
3.9 years
June 30, 2020
April 14, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Mean change in insomnia as measured by the Insomnia Severity Index (ISI) total score comparing cancer survivors in YOCAS vs. Standard Care
The Insomnia Severity Index is a validated measure of insomnia. A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. A linear mixed effects ANCOVA will be used to assess the statistical significance of the differences in mean change among cancer survivors in YOCAS vs. Standard Care
baseline to week 5
Secondary Outcomes (1)
Mean Change in sleep quality as measured by the Pittsburgh Sleep Quality Inventory (PSQI) total Score comparing cancer survivors in YOCAS vs. Standard Care
baseline to week 5
Study Arms (2)
Standard Care
ACTIVE COMPARATORCancer survivors receive their standard care
YOCAS
EXPERIMENTALCancer survivors receive 8 virtual yoga sessions (75 minutes/session, 2 times a week for 4 weeks) delivered via an electronic platform (e.g., Zoom)
Interventions
Standard Care is used as a control condition. Cancer survivors assigned to this arm continue to receive standard care from their medical providers.
Yoga for Cancer Survivors, YOCAS©®, intervention is a low to moderate intensity mode of exercise that draws from two basic types of yoga; gentle Hatha and Restorative yoga. The program includes specific physical postures and mindfulness exercises focused on breathing and meditation. Cancer survivors will participate in 8 virtual YOCAS sessions (75 minutes/session, 2 times a week for 4 weeks) delivered via an electronic platform (e.g., Zoom)
Eligibility Criteria
You may qualify if:
- Cancer Survivors must:
- have a confirmed diagnosis of cancer
- have received surgery, chemotherapy, and/or radiation therapy
- have completed all surgery, chemotherapy, and/or radiation therapy within the last 2 months to 10 years
- score ≥4 on a 0-10 sleep screening scale
- be at least 18 years of age
- be able to read and understand English
- be able to provide informed consent
- have access to the internet and a smartphone, tablet, and/or computer
- have the ability to attend 8 virtual yoga sessions
You may not qualify if:
- Cancer Survivor must not:
- have contraindications to yoga participation
- have practiced yoga within the 3 months prior to enrolling in the study
- be planning to start yoga on their own during the time they are enrolled in the study
- have a confirmed diagnosis of sleep apnea or restless leg syndrome
- be receiving any form of treatment for cancer with the exception of hormonal or biologic therapy
- have distant metastases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Rochesterlead
- Bassett Medical Centercollaborator
Study Sites (2)
Bassett Research Institute
Cooperstown, New York, 13326, United States
University of Rochester Medical Center
Rochester, New York, 14642, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karen Mustian, PhD, MPH
University of Rochester
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 30, 2020
First Posted
July 7, 2020
Study Start
January 12, 2022
Primary Completion
November 30, 2025
Study Completion (Estimated)
November 30, 2026
Last Updated
April 16, 2026
Record last verified: 2026-04